SCHEMBL2118558

SCHEMBL2118558

CCCSc1ncnc2nc[nH]c12

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 1/20 0.82
NPC1 O15118 3/20 0.64
LMNA P02545 3/20 0.64
RAB9A P51151 3/20 0.64
HTT P42858 3/20 0.64
TP53 P04637 1/20 0.62
HSD17B10 Q99714 1/20 0.62
TSHR P16473 2/20 0.61
G6PD P11413 1/20 0.61
CDC7 O00311 7/20 0.59
DBF4 Q9UBU7 7/20 0.59
MAPT P10636 1/20 0.57
CYP2C19 P33261 1/20 0.57
HIF1A Q16665 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
NPSR1 Q6W5P4 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1725584 0.90 PAK1 (1.00) PAK1NPC1LMNARAB9AHTT
SCHEMBL10927540 0.89 PAK1 (0.97) PAK1NPC1LMNARAB9AHTT
SCHEMBL8642694 0.89 PAK1 (0.97) PAK1NPC1LMNARAB9AHTT
SCHEMBL9465617 0.89 PAK1 (0.97) PAK1NPC1LMNARAB9AHTT
SCHEMBL2115555 0.86 PAK1 (0.71) PAK1NPC1LMNARAB9AHTT
SCHEMBL31439407 0.86 PAK1 (0.71) PAK1NPC1LMNARAB9AHTT
SCHEMBL9443835 0.85 PAK1 (0.89) PAK1NPC1LMNARAB9AHTT
SCHEMBL10435438 0.81 PAK1 (0.69) PAK1NPC1LMNARAB9AHTT
SCHEMBL30694105 0.80 PAK1 (0.67) PAK1NPC1LMNARAB9AHTT
SCHEMBL23625010 0.78 PAK1 (0.65) PAK1NPC1LMNARAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150119351-A1 THERAPY OF TUMORS AND INFECTIOUS AGENTS DEFICIENT IN METHYLTHIOADENOSINE PHOSPHORYLASE LUBIN ADAM (US) 2015-04-30 US disclosed
US-8796241-B2 Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase LUBIN ADAM (US) 2014-08-05 US disclosed
US-20120094947-A1 METHOD FOR THE SELECTIVE THERAPY OF DISEASE LUBIN ADAM (US) 2012-04-19 US disclosed
EP-2192905-A2 METHOD FOR THE SELECTIVE THERAPY OF DISEASE Lubin, Adam (US) 2010-06-09 EP disclosed
WO-2009032057-A2 METHOD FOR THE SELECTIVE THERAPY OF DISEASE LUBIN ADAM (US) 2009-03-12 WO disclosed
US-5213972-A Production of thymidine and deoxyuridine, intermediates for AZT CHEMGEN CORPORATION (US) 1993-05-25 US disclosed